Send Enquiry

MEDANOR
Syrup
Packaging and packing Type
| 100ml
MRP :
₹91.88
PTR :
₹70
PTS :
₹63
Prescription medicine Read More
Composition
Send Enquiry
Available on PCD franchise with monopoly rights: Respiratory PCD franchise
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Broxokof LS Syrup (womc) is a syrup from Vibcare Pharma. The formulation has Levosalbutamol 1 mg, Ambroxol 30 mg and Guaifenesin 50 mg in the respiratory and cough syrup class. It is packed as 100ml and is available from Vibcare Pharma's Medanor division.
Three ingredients work together in this syrup. Levosalbutamol relaxes the muscles of the airways and eases bronchospasm. Ambroxol, a mucolytic, loosens thick mucus so it can leave the bronchial tubes. Guaifenesin is an expectorant that thins bronchial secretions and assists in clearing phlegm from the chest.
It is used for cough with bronchospasm, chest congestion and wheezing in reversible obstructive airway disease.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
For distributors and medical representatives
Broxokof LS Syrup is part of Vibcare Pharma's respiratory range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.
Broxokof LS Syrup (womc) is used for cough with bronchospasm, wheezing and phlegm in the chest. Main uses: relief of cough that comes with wheezing and bronchospasm in reversible obstructive airway disease; loosening and clearing of thick mucus and phlegm from the bronchial tubes; relief of chest congestion with a productive cough; easing of airflow when bronchial smooth muscle is tight in reversible airway obstruction.
Common side effects of Broxokof LS Syrup include trembling or shakiness of the hands; palpitations or awareness of the heartbeat; headache; nausea or vomiting; stomach discomfort; dizziness. Get medical help at once if you notice paradoxical bronchospasm with sudden wheezing and breathing difficulty; severe allergic reactions such as rash, swelling of the face or throat, or anaphylaxis; rapid or irregular heartbeat.
Broxokof LS Syrup contains Levosalbutamol 1 mg + Ambroxol 30 mg + Guaifenesin 50 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Broxokof LS Syrup only as your doctor advises.
The MRP of Broxokof LS Syrup is ₹91.88 for a pack of 100ml. For chemists and distributors, the PTR is ₹70 and the PTS is ₹63.
Broxokof LS Syrup contains Levosalbutamol 1 mg + Ambroxol 30 mg + Guaifenesin 50 mg. It comes in a pack of 100ml.
Three ingredients work together in this syrup. Levosalbutamol relaxes the muscles of the airways and eases bronchospasm. Ambroxol, a mucolytic, loosens thick mucus so it can leave the bronchial tubes. Guaifenesin is an expectorant that thins bronchial secretions and assists in clearing phlegm from the chest.
Must not be used by patients with a known allergy to Levosalbutamol, Ambroxol, Guaifenesin or any other ingredient of the syrup. Check with a doctor first if you have heart disease, high blood pressure, an irregular heartbeat or an overactive thyroid. Check with a doctor first if you have diabetes, epilepsy or low blood potassium. Check with a doctor first if you are pregnant or breastfeeding. Check with a doctor first before giving this syrup to young children.
Broxokof LS Syrup is a brand of Vibcare Pharma, sold through its Medanor division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner